Thrombolytic therapy in acute MI. Weighing the risks and benefits
Ro, K.G.; Anderson, H.V.
Postgraduate Medicine 88(8): 79-80 83-6 89-90 Passim
1990
ISSN/ISBN: 0032-5481 PMID: 2123035 Document Number: 347565
The underlying cause of acute myocardial infarction can now be effectively treated with thrombolytic agents, thereby increasing myocardial salvage and reducing mortality. Clinicians should always be aware of the risk-to-benefit ratio in treating patients with thrombolytic agents and treat each patient on an individual basis.
Document emailed within 1 workday
Related Documents
Kent, D.M.; Lau, J.; Selker, H.P. 2001: Balancing the benefits of primary angioplasty against the benefits of thrombolytic therapy for acute myocardial infarction: the importance of timing Effective Clinical Practice: Ecp 4(5): 214-220Marchant, B.G.; Timmis, A.D. 1993: Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation British Journal of Hospital Medicine 49(3): 186-190
Savchenko, A.P.; Leisch, F.; Pomerantsev, E.V.; Kirschner, K. 1991: Delayed balloon dilatation of the coronary arteries after thrombolytic therapy in acute myocardial infarct: a comparison with thrombolytic therapy Terapevticheskii Arkhiv 63(8): 56-61
Goldstein, S. 2002: Benefits of beta-blocker therapy for heart failure: weighing the evidence Archives of Internal Medicine 162(6): 641-648
Cieslinski, G.; Klepzig, H. 1993: Therapy of acute myocardial infarct with thrombolytic drugs. Can use of thrombolytic therapy be further improved? Fortschritte der Medizin 111(13): 209
Kothe, K. 1990: Thrombolytic therapy in acute myocardial infarct. 2. Clinical studies with thrombolytic therapy Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 45(10): 269-274
Kothe, K. 1990: Thrombolytic therapy in acute myocardial infarct. 1. Markers for evaluating effectiveness and thrombolytic substances Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 45(7): 177-183
Kovacs, G.T.; Chick, P. 1990: Hormone replacement therapy at the menopause. the risks and benefits Australian Family Physician 19(1): 73
Leonhardt, G.; Weiller, C.; Müllges, W.; Korbmacher, G.; Ringelstein, E.B. 1991: Anticoagulation in acute cerebral infarct. Benefits, risks, therapeutic failures Der Nervenarzt 62(8): 470-476
Warren, M.P. 2010: Hormone therapy for menopausal symptoms: putting benefits and risks into perspective Journal of Family Practice 59(12): E1-E7
Magnusson, C.; Persson, I. 1997: Hormone therapy in climacteric. Varying research results on risks and benefits Lakartidningen 94(13): 1176-1179
Tollemar, J.; Tydén, G.; Brattström, C.; Groth, C.G. 1988: Anticoagulation therapy for prevention of pancreatic graft thrombosis: benefits and risks Transplantation Proceedings 20(3): 479-480
Ouattara, E.N.; Anglaret, X.; Wong, A.Y.; Chu, J.; Hsu, H.E.; Danel, C.; Eholié, S.; Moh, R.; Gabillard, D.; Walensky, R.P.; Freedberg, K.A. 2012: Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age Aids 26(5): 625-634
Soriano, V.; Rivas, P.; Nuñez, M. 2008: Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 47(11): 1486-1489
2006: Osteoporosis drugs and jaw problems. Weighing your risks Mayo Clinic Health Letter 24(12): 6
Hawken, P.L.; Hillestad, E.A. 1987: Weighing the costs and the benefits of students education to service agencies Nursing and Health Care: Official Publication of the National League for Nursing 8(4): 223-227
Rosen, B.; Irvine, J.; Ritvo, P.; Shapiro, H.; Stewart, D.; Reynolds, K.; Robinson, G.; Thomas, J.; Neuman, J.; Murphy, J. 1997: The feasibility of assessing women's perceptions of the risks and benefits of fertility drug therapy in relation to ovarian cancer risk Fertility and Sterility 68(1): 90-94
Anglaret, X.; Scott, C.A.; Walensky, R.P.; Ouattara, E.; Losina, E.; Moh, R.; Becker, J.E.; Uhler, L.; Danel, C.; Messou, E.; Eholié, S.; Freedberg, K.A. 2013: Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? a model-based analysis Antiviral Therapy 18(1): 45-55
Wahl, D.G.; Bounameaux, H.; de Moerloose, P.; Sarasin, F.P. 2000: Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis Archives of Internal Medicine 160(13): 2042-2048
Nandigam, K.; Narayan, S.K.; Elangovan, S.; Dutta, T.K.; Sethuraman, K.R.; Das, A.K. 2003: Feasibility of acute thrombolytic therapy for stroke Neurology India 51(4): 470-473